Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- Check5 days agoChange DetectedRecruitment status now shows the study is no longer enrolling participants. The record history updates to include revision v3.6.0 and removes the previous revision v3.5.5 entry.SummaryDifference0.4%

- Check12 days agoChange DetectedThe record history adds a new revision label, Revision: v3.5.5, updating the version shown in the history. It replaces the previous Revision: v3.5.4, reflecting a minor administrative update to the page metadata.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new revision entry 'Revision: v3.5.4' to the study record history and removed the previous 'Revision: v3.5.3'. This update updates the history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check55 days agoChange DetectedA site/interface revision indicator on the record history page was updated from version v3.5.2 to v3.5.3. This represents a background system/version change rather than a modification to the clinical trial record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed in the study history.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.